Study finds certain drugs cut Alzheimer's

December 6, 2006

U.S. scientists say they've identified anti-hypertensive agents that can prevent cognitive decline and amyloid neuropathology in Alzheimer patients.

The research, conducted by Dr. Giulio Maria Pasinetti and colleagues at the Mount Sinai School of Medicine, suggests a large number of geriatric patients under pharmacological treatment for high-blood pressure with certain anti-hypertensive drugs might also reap the benefits of the drug's cognitive effects.

Pasinetti's research is part of a growing push to identify and develop more effective treatments for Alzheimer's disease.

"There is no convincing evidence that there is any available drug presently on the market to cure Alzheimer's disease and there are many questions surrounding the effectiveness of drugs that are available to delay or effectively alleviate symptoms of memory deterioration or dementia," said Pasinetti.

During the past two years, researchers have begun screening drugs already commercially available for treatment of other disorders to determine their potential value in treating Alzheimer's disease and cognitive impairment.

Pasinetti's findings were presented Wednesday in New York during the American College of Neuropsychopharmacology's annual conference.

Copyright 2006 by United Press International

Explore further: New guideline provides clinical recommendations for specific insomnia drugs

Related Stories

Marijuana policy has outpaced science, says researcher

February 6, 2017

With marijuana legalization advancing in several states, including Massachusetts, scientists are working to answer questions about the drug's effectiveness as a medicine and its impact on health and the brain.

Virtually painless – how VR is making surgery simpler

January 31, 2017

Surgeons and their patients are finding that virtual reality can relieve the pain and stress of operations – and it's safer and cheaper than sedatives. Jo Marchant travels to a Mexican mountaintop village to visit a clinic ...

Recommended for you

Researchers identify drug that alleviates opioid withdrawal

January 30, 2017

Opioid use and abuse is a significant social, health and economic issue in Canada. Researchers at the University of Calgary's Faculty of Veterinary Medicine (UCVM) and Hotchkiss Brain Institute (HBI) have discovered that ...

Detecting counterfeit medicines

January 27, 2017

Bernard Naughton and Dr David Brindley from Oxford University's Saïd Business School and Medical Sciences Division discuss the problems of identifying fake, substandard and expired medicines.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.